News Category
MindWave Innovations is building an interconnected blockchain ecosystem to support institutional digital finance, emphasizing infrastructure over cryp...
HWAL Inc. is integrating music preservation, intellectual property management, and emerging technologies to monetize a $480 million catalog and expand...
Stewards, Inc. (NASDAQ: SWRD) has received approval to uplist its common stock to the Nasdaq Capital Market, a move that could enhance its visibility ...
FingerMotion's new management has improved liquidity and reduced cash burn by nearly 30%, signaling a strategic shift toward North American enterprise...
Regentis Biomaterials reported positive progress in its Phase III GelrinC trial and received European approval for a manufacturing process that boosts...
Saudi Arabia's rapid crypto transaction growth is reshaping the MENA digital asset landscape, potentially attracting major exchanges like Coinbase as ...
Renewable energy and battery storage are providing a proven solution to longstanding grid challenges, as demonstrated in Texas, offering backup capaci...
Reports that OpenAI agents hacked a German website highlight the urgent need for robust AI security and ethical governance as autonomous systems grow ...
Greenland Mines' completed Sarfartoq rare earths acquisition, active 2026 Skaergaard drilling, pending resource update, and AnorTech stake option repr...
Quantum BioPharma's FDA clearance to launch a Phase 2 trial of Lucid-MS, a first-in-class myelin-protecting drug, could revolutionize multiple scleros...
TransCode Therapeutics has named John Tattory as interim CFO following Tom Fitzgerald's retirement, bringing extensive financial leadership to support...
Earth Science Tech Inc. reported strong revenue growth and a strengthened balance sheet, highlighting the success of its vertically integrated B2B-B2C...
Perpetuals.com Ltd. and the European Institute of Management have formed a joint research group to develop AI-powered trading models, leveraging propr...
Trilogy Metals' inclusion in the 2026 TSX30 highlights its exceptional stock performance and the strategic importance of its Arctic Project to the U.S...
Quantum BioPharma's Lucid-MS, a first-in-class PAD2 inhibitor, has received FDA clearance to begin a Phase 2 trial in multiple sclerosis, marking a si...
Quantum BioPharma's FDA clearance for a Phase 2 trial of Lucid-MS marks the first time a drug designed to protect and rebuild myelin will be tested in...
Quantum BioPharma's Lucid-MS, a first-in-class myelin-protecting and potentially regenerating therapy, receives FDA clearance for a Phase 2 trial, mar...
American Fusion Inc. (OTC: AMFN) released an interview detailing its Texatron(TM) fusion engine development and its strategy to meet growing electrici...
Helus Pharma's CEO Michael Halstead will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference, providing a pl...
Rezolve Ai's CEO will participate in a major investment conference and the company will host an Investor Day to showcase its agentic commerce and AI i...
Lahontan Gold Corp. has appointed Billy Choi as its new chief financial officer, a strategic move that strengthens its financial leadership as the com...
American Fusion Inc. has advanced its Texatron Fusion Engine program into active testing, achieving peak confinement pressures of approximately 100,00...
Quantum BioPharma's FDA clearance for its Lucid-MS IND allows a phase 2 trial in multiple sclerosis, potentially offering a first-in-class treatment t...
American Fusion has advanced its Texatron fusion program into active testing, achieving peak pressures of 100,000 atmospheres while attracting new res...
Forward Industries is pressing SkyAI shareholders to oppose a dilutive equity plan and withhold support for directors due to governance and valuation ...
Greenland Mines Ltd. completes acquisition of Neo North Star Resources, adding the Sarfartoq rare earths project to its portfolio, shifting from a sin...
Kairos Pharma's CEO presentation at a major investment conference underscores the clinical progress of its lead candidate ENV-105, which aims to rever...
Electric vehicle sales in the U.S. have dropped significantly after the federal tax credit ended, leading to speculation that EVs may become niche pro...
Fairchild Gold's engagement of TerraEye for a property-wide spectral mapping and structural interpretation program at its Golden Arrow project signals...
Quantum BioPharma's FDA clearance for Lucid-MS Phase 2 trial marks a pivotal step toward a novel therapy that could repair myelin, potentially transfo...
Quantum BioPharma's Lucid-MS, a first-in-class myelin-protective candidate for multiple sclerosis, has received FDA clearance for a Phase 2 trial and ...
Helus Pharma's CEO participation in the H.C. Wainwright conference highlights the company's progress in developing novel treatments for mental health ...
Mobix Labs' initial production order for F-16 components underscores its growing role in major U.S. fighter programs, with implications for defense su...
SS Innovations International is expanding its SSi Mantra surgical robotic system globally, with strong revenue growth and an expanding installed base,...
Mobix Labs has received its first production order for components supporting the F-16 Fighting Falcon, marking a strategic expansion of its defense po...
Faraday Future's participation in the Moody Capital conference underscores its strategic pivot to Physical AI and robotics, signaling a transformative...
Cyabra’s participation in the Moody Capital conference underscores the growing importance of AI-powered narrative intelligence in combating disinforma...
Impala Platinum's substantial dividend payout highlights the PGM sector's rebound, prompting investors to watch how other producers allocate profits.
LaFleur Minerals is strategically positioned to become a near-term gold producer by recommissioning its fully permitted Beacon Gold Mill, leveraging t...
Quantum BioPharma's FDA clearance to begin a Phase 2 trial of Lucid-MS, a first-in-class drug targeting demyelination in multiple sclerosis, marks a s...
Quantum BioPharma has received FDA clearance to begin a Phase 2 trial of its novel multiple sclerosis drug candidate Lucid-MS, marking a significant s...
The 2026 Moody Capital Disruptive Growth & Life Sciences Conference is uniquely positioned to address the converging investment opportunities in life ...
Interlink Electronics announces its participation in the Moody Capital 2026 conference, underscoring its strategic growth in sensors and printed elect...
The LGL Group's participation in the Moody Capital Solutions conference underscores its commitment to strategic investments in critical technologies a...
Focus Universal's exercise of warrants for $3.7 million provides essential capital to advance its IoT and 5G product lines, signaling financial suppor...
Shenzhen HQVT Technology's interim results show 84.5% revenue growth driven by multispectral AI, with Stock Connect inclusion set to boost liquidity a...
Focus Universal Inc. announced the exercise of warrants for approximately $3.7 million in gross proceeds, which will fund development of its IoT and 5...
VERAXA Biotech's appointment of seasoned financial executive Raju Willener as CFO signals a strategic move to strengthen its capital strategy and supp...
